A new study published in the journal eGastroenterology provides an updated assessment of the diagnosis, pathophysiology, and treatment of hepatorenal syndrome-acute kidney injury (HRS-AKI). This severe and often fatal condition ...
Nov 30, 2023
0
0
Kidney stones affect nearly 10% of the global population. For more than three decades, thiazide diuretics, a common medication used for high blood pressure, have been the standard of care for kidney stone prevention because ...
Nov 30, 2023
0
20
Two-week direct-acting antiviral (DAA) prophylaxis prevents hepatitis C virus (HCV) infection in individuals without HCV viremia who received kidney transplant (KT) from donors with HCV viremia (HCV D+/R−), according to ...
Nov 28, 2023
0
1
From 2014 to 2021, uptake of disease-modifying treatments (DMTs) for sickle cell disease (SCD) remained low, according to a study published in the journal JAMA Network Open.
Nov 27, 2023
0
0
As global temperatures continue to soar due to anthropogenic climate change, a new study has highlighted the alarming consequences of heat stress on outdoor workers. The research, published in Kidney International Reports, ...
Nov 27, 2023
0
0
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following ...
Nov 22, 2023
0
21
Researchers from the University Medical Center Hamburg-Eppendorf and the University Hospital Bonn have demonstrated that certain derivatives of vitamin B2 can alleviate chronic kidney inflammation in mice. Their findings ...
Nov 21, 2023
0
152
Despite a record year for organ donation last year in the U.S., an estimated 17 people die every day waiting for a transplant. Yet Mayo Clinic transplant experts are optimistic that solutions to some of the biggest transplant ...
Nov 16, 2023
0
0
The annual meeting of the American Society of Nephrology (Kidney Week) was held this year from Nov. 2 to 5 in Philadelphia and attracted participants from around the world, including nephrology specialists, researchers, scientists, ...
Nov 15, 2023
0
0
In a post hoc analysis of the Phase II NOBILITY trial, researchers found that treatment with obinutuzumab—an antibody that targets a protein expressed on certain immune cells—was superior to placebo for preserving kidney ...
Nov 10, 2023
0
1
